We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 23, 2020

Change of Outcomes Over a 10-Year Period in Patients With Stage III Colon Cancer Treated With FOLFOX or FLOX

Annals of Oncology


Additional Info

Annals of Oncology
Evaluation of the Change of Outcomes Over a Ten-Year Period in Patients With Stage III Colon Cancer: Pooled Analysis of 6501 Patients Treated With Fluorouracil, Leucovorin, and Oxaliplatin in the ACCENT Database
Ann. Oncol 2020 Jan 16;[EPub Ahead of Print], ME Salem, J Yin, RM Goldberg, et al

Further Reading